{"id":755567,"date":"2023-05-05T08:15:54","date_gmt":"2023-05-05T12:15:54","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-first-quarter-financial-results-and-provide-corporate-update-on-may-12-2023\/"},"modified":"2023-05-05T08:15:54","modified_gmt":"2023-05-05T12:15:54","slug":"humacyte-to-present-first-quarter-financial-results-and-provide-corporate-update-on-may-12-2023","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-first-quarter-financial-results-and-provide-corporate-update-on-may-12-2023\/","title":{"rendered":"Humacyte to Present First Quarter Financial Results and Provide Corporate Update on May 12, 2023"},"content":{"rendered":"
\n

DURHAM, N.C., May 05, 2023 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale, will release its financial results for the first quarter ended March 31, 2023, on Friday, May 12, 2023. Management will host a webcast and conference call at 8:00 a.m. ET to provide a corporate and financial update.<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n
\n Title:<\/strong>\n <\/td>\n\u00a0<\/td>\nHumacyte First Quarter 2023 Financial Results and Corporate Update<\/td>\n<\/tr>\n
\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n
\n Date:<\/strong>\n <\/td>\n\u00a0<\/td>\nFriday, May 12, 2023<\/td>\n<\/tr>\n
\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n
\n Time:<\/strong>\n <\/td>\n\u00a0<\/td>\n8:00 AM ET<\/td>\n<\/tr>\n
\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n
\n Conference Call Details:<\/strong>\n <\/td>\n\u00a0<\/td>\nToll-Free: 1-877-704-4453
International: 1-201-389-0920
Conference ID#: 13738048<\/td>\n<\/tr>\n
\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n
\n Call me\u2122 Feature (avoid waiting for operator):<\/strong>\n <\/td>\n\u00a0<\/td>\n\n Click Here<\/a>
\n \n <\/td>\n<\/tr>\n
\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n
\n Webcast:<\/strong>\n <\/td>\n\u00a0<\/td>\n\n Webcast Link \u2013 Click Here<\/a>\n <\/td>\n<\/tr>\n<\/table>\n

\n \n <\/p>\n

The webcast should be accessed 15 minutes prior to the conference call start time. A replay of the webcast will be available following the conclusion of the live broadcast and will be accessible on the investors section of the Company\u2019s website for at least 30 days.<\/p>\n

\n About Humacyte<\/strong>
\n
Humacyte, Inc. (Nasdaq: HUMA) is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues, advanced tissue constructs, and organ systems designed to improve the lives of patients and transform the practice of medicine. The company develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Humacyte\u2019s initial opportunity, a portfolio of HAVs, is currently in late-stage clinical trials targeting multiple vascular applications, including vascular trauma repair, AV access for hemodialysis, and peripheral arterial disease. Preclinical development is also underway in coronary artery bypass grafts, pediatric heart surgery, treatment of type 1 diabetes, and multiple novel cell and tissue applications. Humacyte\u2019s 6mm HAV for AV access in hemodialysis was the first product candidate to receive the FDA\u2019s Regenerative Medicine Advanced Therapy (RMAT) designation and has also received FDA Fast Track designation. Humacyte\u2019s 6mm HAV for urgent arterial repair following extremity vascular trauma also has received RMAT designation. The HAV received priority designation for the treatment of vascular trauma by the U.S. Secretary of Defense. For more information, visit www.Humacyte.com<\/a>.<\/p>\n

\n Humacyte Investor Contact:<\/strong>
\n
Joyce Allaire
LifeSci Advisors LLC
+1-617-435-6602
jallaire@lifesciadvisors.com<\/a>
investors@humacyte.com<\/a><\/p>\n

\n Humacyte Media Contact:<\/strong>
\n
Rich Luchette
Precision Strategies
+1-202-845-3924
rich@precisionstrategies.com<\/a>
media@humacyte.com<\/a><\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

DURHAM, N.C., May 05, 2023 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale, will release its financial results for the first quarter ended March 31, 2023, on Friday, May 12, 2023. Management will host a webcast and conference call at 8:00 a.m. ET to provide a corporate and financial update. Title: \u00a0 Humacyte First Quarter 2023 Financial Results and Corporate Update \u00a0 \u00a0 \u00a0 Date: \u00a0 Friday, May 12, 2023 \u00a0 \u00a0 \u00a0 Time: \u00a0 8:00 AM ET \u00a0 \u00a0 \u00a0 Conference Call Details: \u00a0 Toll-Free: 1-877-704-4453International: 1-201-389-0920Conference ID#: 13738048 \u00a0 \u00a0 \u00a0 Call me\u2122 Feature (avoid waiting for operator): \u00a0 Click Here \u00a0 \u00a0 \u00a0 Webcast: … <\/p>\n

Continue reading “Humacyte to Present First Quarter Financial Results and Provide Corporate Update on May 12, 2023”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-755567","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nHumacyte to Present First Quarter Financial Results and Provide Corporate Update on May 12, 2023 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-first-quarter-financial-results-and-provide-corporate-update-on-may-12-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Humacyte to Present First Quarter Financial Results and Provide Corporate Update on May 12, 2023 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"DURHAM, N.C., May 05, 2023 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale, will release its financial results for the first quarter ended March 31, 2023, on Friday, May 12, 2023. Management will host a webcast and conference call at 8:00 a.m. ET to provide a corporate and financial update. Title: \u00a0 Humacyte First Quarter 2023 Financial Results and Corporate Update \u00a0 \u00a0 \u00a0 Date: \u00a0 Friday, May 12, 2023 \u00a0 \u00a0 \u00a0 Time: \u00a0 8:00 AM ET \u00a0 \u00a0 \u00a0 Conference Call Details: \u00a0 Toll-Free: 1-877-704-4453International: 1-201-389-0920Conference ID#: 13738048 \u00a0 \u00a0 \u00a0 Call me\u2122 Feature (avoid waiting for operator): \u00a0 Click Here \u00a0 \u00a0 \u00a0 Webcast: … Continue reading "Humacyte to Present First Quarter Financial Results and Provide Corporate Update on May 12, 2023"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-first-quarter-financial-results-and-provide-corporate-update-on-may-12-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-05T12:15:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMjY1NiM1NTc2OTM5IzUwMDExNDk0Mw==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humacyte-to-present-first-quarter-financial-results-and-provide-corporate-update-on-may-12-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humacyte-to-present-first-quarter-financial-results-and-provide-corporate-update-on-may-12-2023\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Humacyte to Present First Quarter Financial Results and Provide Corporate Update on May 12, 2023\",\"datePublished\":\"2023-05-05T12:15:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humacyte-to-present-first-quarter-financial-results-and-provide-corporate-update-on-may-12-2023\\\/\"},\"wordCount\":374,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humacyte-to-present-first-quarter-financial-results-and-provide-corporate-update-on-may-12-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzMjY1NiM1NTc2OTM5IzUwMDExNDk0Mw==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humacyte-to-present-first-quarter-financial-results-and-provide-corporate-update-on-may-12-2023\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humacyte-to-present-first-quarter-financial-results-and-provide-corporate-update-on-may-12-2023\\\/\",\"name\":\"Humacyte to Present First Quarter Financial Results and Provide Corporate Update on May 12, 2023 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humacyte-to-present-first-quarter-financial-results-and-provide-corporate-update-on-may-12-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humacyte-to-present-first-quarter-financial-results-and-provide-corporate-update-on-may-12-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzMjY1NiM1NTc2OTM5IzUwMDExNDk0Mw==\",\"datePublished\":\"2023-05-05T12:15:54+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humacyte-to-present-first-quarter-financial-results-and-provide-corporate-update-on-may-12-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humacyte-to-present-first-quarter-financial-results-and-provide-corporate-update-on-may-12-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humacyte-to-present-first-quarter-financial-results-and-provide-corporate-update-on-may-12-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzMjY1NiM1NTc2OTM5IzUwMDExNDk0Mw==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzMjY1NiM1NTc2OTM5IzUwMDExNDk0Mw==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humacyte-to-present-first-quarter-financial-results-and-provide-corporate-update-on-may-12-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Humacyte to Present First Quarter Financial Results and Provide Corporate Update on May 12, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Humacyte to Present First Quarter Financial Results and Provide Corporate Update on May 12, 2023 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-first-quarter-financial-results-and-provide-corporate-update-on-may-12-2023\/","og_locale":"en_US","og_type":"article","og_title":"Humacyte to Present First Quarter Financial Results and Provide Corporate Update on May 12, 2023 - Market Newsdesk","og_description":"DURHAM, N.C., May 05, 2023 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale, will release its financial results for the first quarter ended March 31, 2023, on Friday, May 12, 2023. Management will host a webcast and conference call at 8:00 a.m. ET to provide a corporate and financial update. Title: \u00a0 Humacyte First Quarter 2023 Financial Results and Corporate Update \u00a0 \u00a0 \u00a0 Date: \u00a0 Friday, May 12, 2023 \u00a0 \u00a0 \u00a0 Time: \u00a0 8:00 AM ET \u00a0 \u00a0 \u00a0 Conference Call Details: \u00a0 Toll-Free: 1-877-704-4453International: 1-201-389-0920Conference ID#: 13738048 \u00a0 \u00a0 \u00a0 Call me\u2122 Feature (avoid waiting for operator): \u00a0 Click Here \u00a0 \u00a0 \u00a0 Webcast: … Continue reading \"Humacyte to Present First Quarter Financial Results and Provide Corporate Update on May 12, 2023\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-first-quarter-financial-results-and-provide-corporate-update-on-may-12-2023\/","og_site_name":"Market Newsdesk","article_published_time":"2023-05-05T12:15:54+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMjY1NiM1NTc2OTM5IzUwMDExNDk0Mw==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-first-quarter-financial-results-and-provide-corporate-update-on-may-12-2023\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-first-quarter-financial-results-and-provide-corporate-update-on-may-12-2023\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Humacyte to Present First Quarter Financial Results and Provide Corporate Update on May 12, 2023","datePublished":"2023-05-05T12:15:54+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-first-quarter-financial-results-and-provide-corporate-update-on-may-12-2023\/"},"wordCount":374,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-first-quarter-financial-results-and-provide-corporate-update-on-may-12-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMjY1NiM1NTc2OTM5IzUwMDExNDk0Mw==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-first-quarter-financial-results-and-provide-corporate-update-on-may-12-2023\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-first-quarter-financial-results-and-provide-corporate-update-on-may-12-2023\/","name":"Humacyte to Present First Quarter Financial Results and Provide Corporate Update on May 12, 2023 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-first-quarter-financial-results-and-provide-corporate-update-on-may-12-2023\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-first-quarter-financial-results-and-provide-corporate-update-on-may-12-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMjY1NiM1NTc2OTM5IzUwMDExNDk0Mw==","datePublished":"2023-05-05T12:15:54+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-first-quarter-financial-results-and-provide-corporate-update-on-may-12-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-first-quarter-financial-results-and-provide-corporate-update-on-may-12-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-first-quarter-financial-results-and-provide-corporate-update-on-may-12-2023\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMjY1NiM1NTc2OTM5IzUwMDExNDk0Mw==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMjY1NiM1NTc2OTM5IzUwMDExNDk0Mw=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-first-quarter-financial-results-and-provide-corporate-update-on-may-12-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Humacyte to Present First Quarter Financial Results and Provide Corporate Update on May 12, 2023"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/755567","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=755567"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/755567\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=755567"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=755567"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=755567"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}